J - AUTONOMIC DYSREFLEXIA (AD)
Evaluation of hyperhidrosis in individuals with SCI at T6, or above T6, should rule out more extensive autonomic dysfunction such as autonomic dysreflexia. (PVA-AD 2020, p.670; Level C)
In the absence of a rise in blood pressure, prevention and management of hyperhidrosis should include identifying other possible triggers. (PVA-AD 2020, p.670; Level C)
In those individuals in whom isolated hyperhidrosis is not associated with an identifiable and modifiable cause, consider empirical treatment with anticholinergic medications unless contraindicated. (PVA-AD 2020, p.670; Level C)
If anticholinergic medications do not relieve hyperhidrosis or are not well tolerated, secondary medications could be considered. (PVA-AD 2020, p.670; Level C)